Family Medicine · Port Gibson, MS
NPI
1528032406
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
405 Market St
Port Gibson, MS, 39150
Phone (601) 437-3323
Groups this clinician bills Medicare through
Medicare paid, 2024
$221K
32,331 services
Medicare patients, 2024
512
Average age 69
Drug cost, 2024
$1.7M
21,286 prescriptions
Company payments, 2025
$5,538
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David M Headley was code J1010 (injection, methylprednisolone acetate, 1 mg), 22,640 times for 158 patients. In total David M Headley billed 32,331 services in 70 codes, and Medicare paid $221K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-04-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 22,640 | 158 | $0.10 | $2,194 |
| 99213 Office E&M - Established | Office | 1,014 | 320 | $47.09 | $48K |
| 99232 Hospital E&M - Subsequent | Facility | 804 | 162 | $51.06 | $41K |
| 96372 Injection Administration | Office | 648 | 230 | $7.56 | $4,902 |
| 99307 SNF E&M | Office | 642 | 80 | $24.49 | $16K |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 519 | 79 | $0.45 | $234 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 378 | 76 | $0.31 | $117 |
| 99309 SNF E&M | Facility | 326 | 35 | $70.76 | $23K |
| 99308 SNF E&M | Facility | 309 | 32 | $49.19 | $15K |
| 99222 Hospital E&M - Initial | Facility | 292 | 174 | $83.40 | $24K |
| 99231 Hospital E&M - Subsequent | Facility | 254 | 62 | $31.72 | $8,056 |
| 99238 Hospital Discharge Management | Facility | 151 | 104 | $52.22 | $7,886 |
| J1040 Injection, methylprednisolone acetate, 80 mg | Office | 151 | 118 | $4.71 | $711 |
| 20610 Joint Injection | Office | 103 | 66 | $37.91 | $3,904 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 85 | 12 | $0.06 | $4.72 |
By year: 2022 $326K for 14,940 services; 2023 $317K for 12,612 services; 2024 $221K for 32,331 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 47 | 40 | $2.20 | $103 |
| 82962 Clinical Chemistry | 15 | 13 | $3.21 | $48.15 |
Medicare prescription drug claims, 2024
In 2024, the drug David M Headley prescribed most often to Medicare patients was Amlodipine Besylate, with 964 prescriptions and refills. In total David M Headley wrote 21,286 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 964 | 1,469 | 218 | $4,911 |
| Potassium Chloride Generic | 789 | 1,076 | 186 | $12K |
| Furosemide Generic | 784 | 1,054 | 189 | $4,809 |
| Metformin Hcl Generic | 514 | 762 | 122 | $3,223 |
| Pantoprazole Sodium Generic | 509 | 697 | 155 | $3,393 |
| Promethazine Hcl Generic | 455 | 456 | 162 | $6,750 |
| Levothyroxine Sodium Generic | 407 | 555 | 71 | $4,125 |
| Cephalexin Generic | 398 | 398 | 253 | $2,458 |
| Atorvastatin Calcium Generic | 369 | 525 | 73 | $3,730 |
| Metoprolol Tartrate Generic | 325 | 460 | 84 | $1,554 |
| Clonidine Hcl Generic | 312 | 437 | 81 | $1,635 |
| Ibuprofen Generic | 308 | 355 | 134 | $3,092 |
| Omeprazole Generic | 306 | 422 | 93 | $3,518 |
| Gabapentin Generic | 299 | 378 | 103 | $3,596 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 293 | 293 | 218 | $3,560 |
Brand drugs: 2,388 claims; generic drugs: 18,832 claims; opioid claims: 427.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David M Headley $5,538 ($38.13 in general payments such as food, travel and fees and $5,500 for research) from 4 companies. The largest payer was Novartis Pharmaceuticals Corporation with $5,500.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.